{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T13:16:06Z","timestamp":1789823766840,"version":"4.0.1"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,8,24]],"date-time":"2018-08-24T00:00:00Z","timestamp":1535068800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Institut Pasteur Ebola Task Force"},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Korea government","award":["NRF-2017M3A9G6068246"],"award-info":[{"award-number":["NRF-2017M3A9G6068246"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.antiviral.2018.08.013","type":"journal-article","created":{"date-parts":[[2018,8,24]],"date-time":"2018-08-24T13:41:17Z","timestamp":1535118077000},"page":"226-237","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["High-throughput drug screening using the Ebola virus transcription- and replication-competent virus-like particle system"],"prefix":"10.1016","volume":"158","author":[{"given":"Nakyung","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Shum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"K\u00f6nig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hichul","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyeong","family":"Heo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saehong","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihye","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoonae","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inhee","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honggun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantin","family":"Radu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Hoenen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Young","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc P.","family":"Windisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2018.08.013_bib1","doi-asserted-by":"crossref","first-page":"4471","DOI":"10.1128\/AAC.00543-16","article-title":"Large-scale screening and identification of novel ebola virus and marburg virus entry inhibitors","volume":"60","author":"Anantpadma","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2018.08.013_bib2","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1056\/NEJMoa1404505","article-title":"Emergence of zaire ebola virus disease in Guinea","volume":"371","author":"Baize","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2018.08.013_bib3","doi-asserted-by":"crossref","first-page":"S425","DOI":"10.1093\/infdis\/jiv223","article-title":"Novel small molecule entry inhibitors of ebola virus","volume":"212","author":"Basu","year":"2015","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2018.08.013_bib4","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1021\/jm9602928","article-title":"The properties of known drugs. 1. Molecular frameworks","volume":"39","author":"Bemis","year":"1996","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2018.08.013_bib30","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1126\/science.1110656","article-title":"Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection","volume":"308","author":"Chandran","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2018.08.013_bib5","unstructured":"ChemIDPlus database, National Library of Medicine, 2017. https:\/\/chem.nlm.nih.gov\/chemidplus\/."},{"key":"10.1016\/j.antiviral.2018.08.013_bib6","doi-asserted-by":"crossref","first-page":"9932","DOI":"10.1128\/JVI.01337-15","article-title":"Inhibition of ebola and marburg virus entry by G Protein-coupled receptor antagonists","volume":"89","author":"Cheng","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.08.013_bib7","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiy304","article-title":"Identification of combinations of approved drugs with synergistic activity against ebola virus in cell cultures","author":"Dyall","year":"2018","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2018.08.013_bib8","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1021\/acsinfecdis.5b00053","article-title":"High-throughput minigenome system for identifying small-molecule inhibitors of ebola virus replication","volume":"1","author":"Edwards","year":"2015","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.antiviral.2018.08.013_bib9","doi-asserted-by":"crossref","first-page":"7260","DOI":"10.1128\/JVI.00051-06","article-title":"Infection of naive target cells with virus-like particles: implications for the function of ebola virus VP24","volume":"80","author":"Hoenen","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.08.013_bib10","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1586\/14787210.2014.948848","article-title":"Reverse genetics systems as tools for the development of novel therapies against filoviruses","volume":"12","author":"Hoenen","year":"2014","journal-title":"Expert Rev. Anti-infect. Ther."},{"key":"10.1016\/j.antiviral.2018.08.013_bib11","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3005471","article-title":"FDA-approved selective estrogen receptor modulators inhibit Ebola virus infection","volume":"5","author":"Johansen","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.antiviral.2018.08.013_bib12","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa5597","article-title":"A screen of approved drugs and molecular probes identifies therapeutics with anti-Ebola virus activity","volume":"7","author":"Johansen","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.antiviral.2018.08.013_bib13","doi-asserted-by":"crossref","first-page":"e84","DOI":"10.1038\/emi.2014.88","article-title":"Identification of 53 compounds that block Ebola virus-like particle entry via a repurposing screen of approved drugs","volume":"3","author":"Kouznetsova","year":"2014","journal-title":"Emerg. Microb. Infect."},{"key":"10.1016\/j.antiviral.2018.08.013_bib14","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1093\/nar\/gkt1068","article-title":"DrugBank 4.0: shedding new light on drug metabolism","volume":"42","author":"Law","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.antiviral.2018.08.013_bib15","doi-asserted-by":"crossref","first-page":"3429","DOI":"10.1016\/j.bmcl.2016.06.053","article-title":"Quinoxaline-based inhibitors of ebola and marburg VP40 egress","volume":"26","author":"Loughran","year":"2016","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.antiviral.2018.08.013_bib16","unstructured":"MESH database, National Library of Medicine, 2017. http:\/\/www.nlm.nih.gov\/mesh\/MBrowser.html."},{"key":"10.1016\/j.antiviral.2018.08.013_bib17","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.antiviral.2015.05.003","article-title":"Inhibitors of cellular kinases with broad-spectrum antiviral activity for hemorrhagic fever viruses","volume":"120","author":"Mohr","year":"2015","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2018.08.013_bib18","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.virol.2011.08.009","article-title":"The Ebola virus glycoprotein mediates entry via a non-classical dynamin-dependent macropinocytic pathway","volume":"419","author":"Mulherkar","year":"2011","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2018.08.013_bib19","doi-asserted-by":"crossref","first-page":"E206","DOI":"10.3390\/v8080206","article-title":"Clomiphene and its isomers block ebola virus particle entry and infection with similar potency: potential therapeutic implications","volume":"8","author":"Nelson","year":"2016","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2018.08.013_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005540","article-title":"The phosphatidylinositol-3-phosphate 5-kinase inhibitor apilimod blocks filoviral entry and infection","volume":"11","author":"Nelson","year":"2017","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.antiviral.2018.08.013_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000141","article-title":"Phosphoinositide-3 kinase-Akt pathway controls cellular entry of Ebola virus","volume":"4","author":"Saeed","year":"2008","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2018.08.013_bib22","doi-asserted-by":"crossref","first-page":"4174","DOI":"10.1128\/JVI.80.8.4174-4178.2006","article-title":"Role of endosomal cathepsins in entry mediated by the Ebola virus glycoprotein","volume":"80","author":"Schornberg","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.08.013_bib23","unstructured":"SciFinder, Chemical Abstract Services, 2017. https:\/\/scifinder.cas.org\/scifinder."},{"key":"10.1016\/j.antiviral.2018.08.013_bib24","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.antiviral.2016.11.017","article-title":"Synergistic drug combination effectively blocks Ebola virus infection","volume":"137","author":"Sun","year":"2017","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2018.08.013_bib25","doi-asserted-by":"crossref","first-page":"10511","DOI":"10.1128\/JVI.01272-14","article-title":"A novel life cycle modeling system for Ebola virus shows a genome length-dependent role of VP24 in virus infectivity","volume":"88","author":"Watt","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.08.013_bib26","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1128\/JVI.72.4.3155-3160.1998","article-title":"Characterization of Ebola virus entry by using pseudotyped viruses: identification of receptor-deficient cell lines","volume":"72","author":"Wool-Lewis","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.08.013_bib27","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/108705719900400206","article-title":"A simple statistical parameter for use in evaluation and validation of high throughput screening assays","volume":"4","author":"Zhang","year":"1999","journal-title":"J. Biomol. Screen"},{"key":"10.1016\/j.antiviral.2018.08.013_bib28","doi-asserted-by":"crossref","first-page":"9218","DOI":"10.1074\/jbc.M116.716100","article-title":"Glycopeptide antibiotics potently inhibit cathepsin L in the late endosome\/lysosome and block the entry of ebola virus, Middle East respiratory syndrome coronavirus (MERS-CoV), and severe acute respiratory syndrome coronavirus (SARS-CoV)","volume":"291","author":"Zhou","year":"2016","journal-title":"J. Biol. Chem."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016635421830398X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016635421830398X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:30:06Z","timestamp":1759062606000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016635421830398X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":29,"alternative-id":["S016635421830398X"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2018.08.013","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-throughput drug screening using the Ebola virus transcription- and replication-competent virus-like particle system","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2018.08.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}